Navigation Links
Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
Date:7/2/2008

TAXUS and PROMUS are trademarks of Boston Scientific Corporation or its affiliates. XIENCE is a trademark of the Abbott Laboratories group of companies. SPIRIT is sponsored by Abbott. The TAXUS Liberte Paclitaxel-Eluting Coronary Stent System is pending approval by the FDA and is not available for sale in the United States.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: http://www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward- looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our product performance, regulatory approval of our products, competitive offerings, our growth strategy, and our market position. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projections expressed or implied by our forward-looking statements. These factors, in some cases, have affected and in the future (together with other factors) could affect our ability to implement our business strategy and may cause actual results to differ materially from those contemplated by the statements expressed in this press release. As a result, readers are cautioned not to place undue reliance on any of our forward
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Boston Scientific to Explore Sale of Cardiac Surgery and Vascular Surgery Businesses
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Boston Scientific Amends Credit Facility and Prepays $1 Billion on Loan
4. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
5. Revolutionary Genomics Research Group Opens Boston Office; Provides DNA Evidence in Workers Comp Cases
6. Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
7. Alliance for Medical Devices, Instrumentation and Diagnostics formed between Fraunhofer Center for Manufacturing Innovation and Boston University
8. Boston Scientific Releases Remote Monitoring Data from its Wireless LATITUDE(R) Patient Management System
9. Genzyme Begins Major Expansion of Boston Manufacturing Facility
10. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
11. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... ... $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and ... aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, ...
(Date:7/6/2015)... UK (PRWEB) , ... July 06, 2015 , ... ... other medical fields holds potential to reveal how blood flows in the brain ... damage to the brain. , A new article published in the journal ...
(Date:7/6/2015)... ... 06, 2015 , ... Discovery of new biomarkers for patient ... of the global molecular diagnostics market. BCC Research reveals in its new report ... diagnostic tests will increase demand for inexpensive and accurate tests for genetic compatibility ...
(Date:7/5/2015)... ... July 06, 2015 , ... For many years, metal-on-quartz filters were ... high-end machine such as a Varian Cary 4000-7000, a Perkin Elmer 800-1100 or a ... that even NIST used them for their SRM-2031 series going back for many years. ...
Breaking Biology Technology:Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 2Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 3Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 4Aptamers Market Growing at 17.89% CAGR to 2020 – New Research Available at RnRMarketResearch.com 5Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 3Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 2Demand for Personalized Medicine, Innovative Molecular Diagnostic Tests Spurring Big Growth, According to BCC Research 3FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 2FireflySci Simplifies the Calibration of UV Spectrophotometers with FUV Photometric Accuracy Standards 3
... DIEGO, May 26, 2011 Sequenom, Inc. (NASDAQ: SQNM)), ... today announced the Company,s participation at the Jefferies 2011 ... New York City, June 6-9, 2011. ... Jr., Ph.D., Chairman and CEO will present on Wednesday, ...
... class of decorative, flower-like defects in the nanomaterial graphene ... unique electrical and mechanical properties, according to researchers at ... Georgia Tech. In a new paper,* the team for ... that could occur naturally or be induced to occur ...
... a new study conducted at the Pennington Biomedical Research Center, ... over the past fifty years is a significant contributor to ... intake cannot solely account for observed trends in weight gain ... The study, entitled "Trends Over 5 Decades in U.S. ...
Cached Biology Technology:Sequenom Announces Participation at Jefferies 2011 Global Healthcare Conference 2Defect in graphene may present bouquet of possibilities 2Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 2Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 3
(Date:7/2/2015)... July 2, 2015 Fingerprint Cards has ... FPC1145 and FPC1155 from the distributor World Peace Industrial Group ... distributors in Asia . Deliveries are planned ... will be used by smartphone manufacturers in Asia ... in the communicated revenue guidance of approximately 2,200 MSEK for ...
(Date:6/26/2015)... 2015 ATL Technology, LLC, a top provider of ... single use solutions, headquartered in Springville, Utah ... California corporation with locations in ... Costa Rica ). This acquisition will incorporate ... with ATL Technology,s existing facility in Costa Rica ...
(Date:6/24/2015)... , June 24, 2015 The biologics ... The major drivers for the market include growth of ... of new drug launches. Over the years, the number ... Between 2001 and 2010, the FDA approved 225 drug ... to WIPO, Europe accounted for ...
Breaking Biology News(10 mins):FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4
... by the problem of "super-bugs" - bacteria that have ... that a high rate of antibiotic prescribing in hospitals ... for some antibiotics, an even more important factor contributing ... the open access international medical journal PLoS Medicine, is ...
... have made an important discovery that will advance our ... of breast cancer cells. The research, in collaboration with ... (IRCM) identifies 153 genes that respond to estrogen and ... the growth of breast cancer cells. The study, published ...
... such as corn, soybeans and sunflowers into fuel uses ... generates, according to a new Cornell University and University ... benefit to using plant biomass for liquid fuel," says ... "These strategies are not sustainable." , Pimentel and Tad ...
Cached Biology News:Agricultural antibiotic use contributes to 'super-bugs' in humans 2Scientists discover genetic pathway responsible for breast cancer cell growth 2Using the genomic shortcut to predict bacterial behavior 2
Contains L-glutamine...
...
... Immunogen: Synthetic peptide derived ... human mouse and rat LRP5. ... and mouse LRP5 proteins. ... mouse LRP5-pSEC-tag-transfected 293T cells MCF-7 ...
...
Biology Products: